Kolon Life Science

Kolon Life Science Dividend Coverage

The Dividend Coverage Ratio of Kolon Life Science (102940.KQ) as of Nov 3, 2026 is 8.33. In the previous year, Dividend Coverage Ratio was 1.20 — a change of 593.99% (higher).

Dividend Coverage

8.33

YoY

593.99%

Last updated:

Dividend Coverage Ratio of Kolon Life Science is 2016 8.33 . Dividend Coverage Ratio of Kolon Life Science was 2015 1.20 . It decreases by 593.99% higher compared to the previous year.

The Kolon Life Science Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2014
4.39 KRW
Jan 1, 2015
1.20 KRW
Jan 1, 2016
8.33 KRW
The Kolon Life Science Dividend Coverage history
YEARDividend CoverageYoY
8.33+593.99%
1.20-72.67%
4.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kolon Life Science Stock analysis

What does Kolon Life Science do? KOLON Life Science, Inc. generates revenue through its Chemical Business segment, which produces and sells raw drug products, antibacterial agents, water treatment agents, and functional material products for cosmetics. The Bio Business segment focuses on manufacturing and selling bio new medicines based on cell gene therapy products. The company's products target pharmaceutical and environmental markets, with raw drug products serving as essential components for new and generic drugs, while antibacterial agents and water treatment agents address healthcare and environmental purification needs. Functional materials for cosmetics represent a key product line within the Chemical Business segment. The company's revenue streams are derived from the sale of pharmaceutical raw materials, antibacterial agents, water treatment solutions, and cosmetic functional materials under the Chemical Business segment. The Bio Business segment contributes through the commercialization of advanced cell gene therapy-based medicines. Both segments operate within the pharmaceutical and environmental sectors, with the Chemical Business serving as the primary revenue driver for raw materials and environmental products, while the Bio Business targets innovative therapeutic solutions in the biopharmaceutical space. KOLON Life Science, Inc. sells its products to the pharmaceutical industry for drug development and manufacturing, as well as to environmental and cosmetic companies requiring specialized materials. The Chemical Business segment's raw drug products are used by pharmaceutical firms to produce new and generic drugs, while antibacterial agents and water treatment agents are supplied to healthcare and environmental purification sectors. Cosmetic functional materials are sold to the cosmetics industry for product development. The Bio Business segment's cell gene therapy products are targeted at biopharmaceutical companies seeking advanced treatment options. Kolon Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kolon Life Science stock

Dividend Coverage Ratio of Kolon Life Science is 8.33 in 2016.

Dividend Coverage Ratio of Kolon Life Science changed from 1.20 to 8.33, representing a 593.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Kolon Life Science since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Kolon Life Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Kolon Life Science

All Key Metrics — Kolon Life Science